Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Diseases of the Colon & Rectum
Published in: Diseases of the Colon & Rectum 1/2007

01-01-2007

The Effect of Capecitabine on the Healing of Colonic Anastomoses in Rats

Authors: Harilaos D. Konstantinidis, M.D., Aristedis P. Slavakis, Ph.D., Konstantinos D. Ballas, M.D., Ph.D., Antonia C. Sioga, M.D., Ph.D., Louise D. Economou, M.D., Ph.D., Charalampos I. Demertzidis, M.D., Theano T. Pissanidou, M.D., Zoi S. Athanasiadou, Ph.D., Athanasios K. Sakadamis, M.D., Ph.D.

Published in: Diseases of the Colon & Rectum | Issue 1/2007

Login to get access

Purpose

Capecitabine is a fluoropyrimidine carbamate with antineoplasmatic activity, recommended for the treatment of colorectal cancer. This study was designed to assess the effectiveness of the perioperative administration of capecitabine on the healing process of colonic anastomosis.

Methods

Sixty Wistar rats were used, which were randomized in 2 groups of 30 each. The study group was subjected to colonic anastomosis and treated with therapeutic doses of capecitabine (359 mg/kg, or 2/3 of the mean toxic dose) by mouth one week before anastomosis and throughout the study. The control group received only placebo medication. Both groups were further divided into three subgroups, each of ten animals. In both study and control groups, ten animals were killed in each session on postoperative Days 3, 7, and 14.

Results

We found no negative impact on the healing of colonic anastomosis on capecitabine administration. The rate of anastomotic leakage and septic complications were not found to be significantly different between the study and control groups. The median bursting pressure was found to be significantly higher in the study subgroup killed on the third day (68 vs. 46 mmHg of the control group).

Conclusions

Perioperative administration of capecitabine does not have a negative impact on colonic anastomosis in rats.
Literature
1.
Edwards, BK, Hone, HL, Ries, LA,  et al. 2002Annual report to the nation of the status of cancer, 1973–1999, featuring implication of age and aging on U.S. cancer burdenCancer9427662792PubMedCrossRef
2.
El-Malt, M, Ceelen, W, Broecke, C,  et al. 2003Influence of neo-adjuvant chemotherapy with 5-fluorouracil on colonic anastomotic healing: experimental study in ratsActa Chir Belg103309314PubMed
3.
Bozdag, AD, Peker, Y, Derici, H, Gurkok, C, Ozgonul, M 2001The effect of preoperative 5-fluorouracil on colonic healing: an experimental studyHepatogastroenterology4816311634PubMed
4.
Kolk, BM, Man, BM, Wobbes, T, Hendriks, T 1999Is early post-operative treatment with 5-fluorouracil possible without affecting anastomotic strength in the intestineBr J Cancer79545550PubMedCrossRef
5.
El-Malt, M, Ceelen, W, Broecke, C,  et al. 2001Healing of experimental colonic anastomoses: effects of combined preoperative high-dose radiotherapy and intraperitoneal 5-fluorouracilInt J Cancer96297304PubMedCrossRef
6.
Cats, A 2003New developments in systemic chemotherapy in advanced colorectal cancerScand J Gastroenterol2397886
7.
Schull, B, Scheithauer, W, Kornek, GV 2003Capecitabine as salvage therapy for a breast cancer patient with extensive liver metastases and associated impairment of liver functionOnkologie26578580PubMedCrossRef
8.
Malet-Martino, M, Jolimaitre, P, Martino, R 2002The prodrugs of 5-fluorouracilCurr Med Chem Anti-Canc Agents2267310CrossRef
9.
Gross, E, Seck, K, Neubauer, S,  et al. 2003High-throughput genotyping by DHPLC of the dihydropyrimidine dehydrogenase gene implicated in (fluoro)pyrimidine catabolismInt J Oncol22325332PubMed
10.
Sawada, N, Ishikawa, T, Fukase, Y, Nishida, M, Yoshikubo, T, Ishitsuka, H 1998Induction of thymidine phosphorylase activity and enhancement of capecitabine efficacy by taxol/taxotere in human cancer xenograftsClin Cancer Res410131019PubMed
11.
Ham, AC, Kort, WJ, Weijma, IM, Ingh, HF, Jeekel, H 1992Effect of antibiotics in fibrin sealant on healing colonic anastomoses in the ratBr J Surg79525528PubMed
12.
Nayci, A, Cakmak, M, Renda, N, Aksoyek, S, Yucesan, S 2003Effect of electromagnetic fields and early postoperative 5-fluorouracil on the healing of colonic anastomosesInt J Colorectal Dis18136141PubMed
13.
Desmoulin, F, Gilard, V, Malet-Martino, M, Martino, R 2002Metabolism of capecitabine, an oral fluorouracil prodrug: (19)F NMR studies in animal models and human urineDrug Metab Dispos3012211229PubMedCrossRef
14.
Miwa, M, Ura, M, Nishida, M,  et al. 1998Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissueEur J Cancer3412741281PubMedCrossRef
15.
Vecchio, M, Procopio, G, Cassata, A,  et al. 1999Fluoropyrimidines in the treatment of advanced neoplastic diseases: role and advantages of UFTTumori85611PubMed
16.
Lewis, NL, Meropol, NJ 2000Oral fluoropyrimidines in cancer treatmentCancer Invest18747760PubMed
17.
18.
19.
Ishikawa, T, Utoh, M, Sawada, N,  et al. 1998Tumor selective delivery of 5-fluorouracil by capecitabine, a new oral fluoropyrimidine carbamate, in human cancer xenograftsBiochem Pharmacol5510911097PubMedCrossRef
20.
Morita, T, Matsuzaki, A, Tokue, A 2001Enhancement of sensitivity to capecitabine in human renal carcinoma cells transfected with thymidine phosphorylase cDNAInt J Cancer92451456PubMedCrossRef
21.
22.
Tanaka, Y, Eda, H, Fujimoto, K, Tanaka, T, Ishigawa, T, Ishitsuka, H 1990Anticachectic activity of 5′-deoxy-5-fluorouridine in murine tumor cachexia model, colon 26 adenocarcinomaCancer Res5045284532PubMed
23.
Tanaka, Y, Eda, H, Tanaka, T,  et al. 1990Experimental cancer cachexia induced by transplantable colon 26 adenocarcinoma in miceCancer Res5022902295PubMed
24.
Portera, CA, Love, EJ, Memore, L,  et al. 1997Effect of macrophage stimulation on collagen biosynthesis in the healing woundAm Surg63125131PubMed
25.
26.
Barbul, A, Breslin, RT, Woodyart, JP, Wasserkrug, HL, Efron, G 1989The effect of in vivo T helper and suppressor lymphocyte depletion on wound healingAnn Surg209479483PubMedCrossRef
27.
28.
Goldman, R 2004Growth factors and chronic wound healing: past, present, and futureAdv Skin Wound Care172435PubMedCrossRef
29.
Siemonsma, MA, Hingh, IH, Man, BM, Lomme, RM, Verhofstad, AA, Hendriks, T 2003Doxycycline improves wound strength after intestinal anastomosis in the ratSurgery133268276PubMedCrossRef
30.
Rostan, EF, DeBuys, HV, Madey, DL, Pinnell, SR 2002Evidence supporting zinc as an important antioxidant for skinInt J Dermatol41606611PubMedCrossRef
31.
Meddahi, A, Benoit, J, Ayoub, N, Sezeur, A, Barritault, D 1996Heparine-like polymers derived from dextran enhance colonic anastomosis resistance on leakageJ Biomed Mater Res3193197
32.
Kiyama, T, Tajiri, T, Tokunaga, A, Yoshiyuki, T, Barbul, A 2002Tacrolimus enhances colon anastomotic healing in ratsWound Repair Regen10308313PubMedCrossRef
33.
Kuzu, MA, Tanik, A, Kale, IT, Aslar, AK, Koksoy, C, Terzi, C 2000Effect of ischemia/reperfusion as a systemic phenomenon on anastomotic healing in the left colonWorld J Surg24990994PubMedCrossRef
34.
Kologlu, M, Yorganci, K, Renda, N, Sayek, I 2000Effect of local and remote ischemia-reperfusion injury on healing of colonic anastomosesSurgery12899104PubMedCrossRef
Metadata
Title
The Effect of Capecitabine on the Healing of Colonic Anastomoses in Rats
Authors
Harilaos D. Konstantinidis, M.D.
Aristedis P. Slavakis, Ph.D.
Konstantinos D. Ballas, M.D., Ph.D.
Antonia C. Sioga, M.D., Ph.D.
Louise D. Economou, M.D., Ph.D.
Charalampos I. Demertzidis, M.D.
Theano T. Pissanidou, M.D.
Zoi S. Athanasiadou, Ph.D.
Athanasios K. Sakadamis, M.D., Ph.D.
Publication date
01-01-2007
Publisher
Springer-Verlag
Published in
Diseases of the Colon & Rectum / Issue 1/2007
Print ISSN: 0012-3706
Electronic ISSN: 1530-0358
DOI
https://doi.org/10.1007/s10350-006-0727-7

Other articles of this Issue 1/2007

Diseases of the Colon & Rectum 1/2007 Go to the issue

OriginalPaper

Colon and Rectal Surgery Regional Society Meetings

Erratum

Botulinum Toxin vs. Topical Glyceryl Trinitrate Ointment for Pain Control in Patients Undergoing Hemorrhoidectomy: A Randomized Trial

Case Reports

Pseudoaneurysm of the Inferior Gluteal Artery: An Unusual Complication After Abdominoperineal Resection for Rectal Cancer. Report of a Case

Current Status

The Role of Positron Emission Tomography in the Management of Recurrent Colorectal Cancer: A Review

OriginalPaper

Lymphatic Vessel Density at the Site of Deepest Penetration as a Predictor of Lymph Node Metastasis in Submucosal Colorectal Cancer

Multimedia Article

Success of Episioproctotomy for Cloaca and Rectovaginal Fistula